Connective Tissue Graft Versus Mucograft Collagen Matrix for Coverage of Multiple Gingival Recession Defects
NCT ID: NCT01440426
Last Updated: 2018-07-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
187 participants
INTERVENTIONAL
2011-09-30
2015-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mucoderm or Connective Tissue Graft for Treatment of Gingival Recessions
NCT03675334
Non-Inferiority of Fibroguide Collagen Membrane Compared to Autologous Connective Tissue Graft for Coverage of Multiple Adjacent Recession. Multicenter Trial.
NCT07083050
Comparison Between Connective Graft and Xenogeneic Matrix, in Patients With Multiple Gingival Recessions
NCT03207984
A Comparision of Collagen Matrix and Connective Tissue Graft With Modified Coronally Advanced Tunnel for Root Coverage
NCT02876562
Treatment of Multiple Gingival Recession Defects Using a New Xenogenic Collagen Membrane Compared to Connective Tissue Graft: a Randomized Controlled Split-mouth Clinical Study
NCT04800250
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The secondary objective is to assess the non-inferiority - in terms of complete root coverage, percentage of root coverage and professional evaluation of aesthetics - of the use of Mucograft Collagen Matrix and autologous connective tissue harvested from the patient's own palate.
Design and Outcomes This will be a parallel group, standard of care-controlled, assessor-blind, randomized, multicenter, multinational, clinical trial.
The statistical design will be a superiority trial in terms of the primary outcomes (patient based outcomes) and non-inferiority trial in terms of the professional outcomes measuring root coverage and aesthetics.
Sample size has been estimated in 140 subjects per treatment arm using a pilot case series analyzed with a multilevel statistical approach and a non inferiority margin of 0.25 mm in recession coverage.
Randomization will be performed by computer generated random codes, using random permuted blocks with a block size of 4 to avoid uneven splits and minimization for the key prognostic factor cigarette smoking. Allocation will be concealed to the surgeons until completion of preparation of the recipient bed by opaque envelopes. A central study registrar will perform patient registration.
Study locations will include academic centers and a practice-based research network in Italy, Switzerland, Germany, Belgium, France, Spain and Greece.
A single examiner, blind with respect to the treatment assignment, will perform all measurements at each center. Trained personnel not involved with the surgical intervention will: i) administer patient questionnaires, ii) provide instructions and collect patient diaries. A single calibrated investigator with specific experience in using the specific score will centrally perform assessment of esthetic scores on standardized digital images.
A biostatistician blind with respect to treatment assignment will perform the analysis.
Interventions and Duration The two intervention groups will consist of surgery with connective tissue graft (standard of care control) and surgery with the application of Mucograft Collagen Matrix (MCM, Test group). Experienced clinicians will deliver treatment consisting of root coverage surgery using coronally advanced flaps, the most utilized procedure for coverage of multiple recessions. Surgery will be standardized and the same procedures/materials will be employed to ensure consistency.
Follow-up of individual patients will be 6 months (to be extended to 3 years if funding will be available)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Autologous connective tissue graft
Soft tissue harvested from patient palate
Autologous connective tissue graft with rotated papilla flap
Subepithelial connective tissue graft harvested from hard palate
Collagen Matrix Construct
Mucograft collagen matrix manufactured by Geistlich AG, Switzerland
Collagen matrix construct (Mucograft)
Mucograft Collagen Matrix combined with rotated papilla flap
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Autologous connective tissue graft with rotated papilla flap
Subepithelial connective tissue graft harvested from hard palate
Collagen matrix construct (Mucograft)
Mucograft Collagen Matrix combined with rotated papilla flap
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The European Research Group on Periodontology (ERGOPerio)
NETWORK
Maurizio Tonetti
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Maurizio Tonetti
Executive DIrector
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maurizio Tonetti, DMD PhD
Role: PRINCIPAL_INVESTIGATOR
The European Research Group on Periodontology (ERGOPerio)
Pierpaolo COrtellini, MD
Role: PRINCIPAL_INVESTIGATOR
The European Research Group on Periodontology (ERGOPerio)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
ICPDOI
Brussels, , Belgium
Praxis Dr. Halben
Hamburg, , Germany
Praxis Prof Huerzeler - Dr Zuhr
Munich, , Germany
Praxis Prof Wachtel - Dr Bolz
Munich, , Germany
Praxis Prof. Topoll
Münster, , Germany
Clinic Fourmousis
Athens, , Greece
University of FLorence
Florence, , Italy
Practice Prof Giulio Rasperini
Piacenza, , Italy
University of Pisa
Pisa, , Italy
Clinia Zabalegui
Bilbao, , Spain
Clinica Guerrero
Málaga, , Spain
Praxis Wallkamm
Langenthal, , Switzerland
Praxis Burkhardt
Zurich, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ERGOPerio 11-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.